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denovirus early region 4 open reading frame 4
(E4orf4) protein has been reported to induce p53-
 
independent, protein phosphatase 2A (PP2A)–depen-
dent apoptosis in transformed mammalian cells. In this re-
port, we show that E4orf4 induces an irreversible growth
 
arrest in 
 
Saccharomyces cerevisiae
 
 at the G
 
2
 
/M phase of
the cell cycle. Growth inhibition requires the presence of
yeast PP2A-Cdc55, and is accompanied by accumulation
of reactive oxygen species. E4orf4 expression is syntheti-
cally lethal with mutants defective in mitosis, including
A
 
Cdc28/Cdk1 and anaphase-promoting complex/cyclosome
(APC/C) mutants. Although APC/C activity is inhibited in
the presence of E4orf4, Cdc28/Cdk1 is activated and par-
tially counteracts the E4orf4-induced cell cycle arrest. The
E4orf4–PP2A complex physically interacts with the APC/C,
suggesting that E4orf4 functions by directly targeting PP2A
to the APC/C, thereby leading to its inactivation. Finally, we
show that E4orf4 can induce G
 
2
 
/M arrest in mammalian
cells before apoptosis, indicating that E4orf4-induced
events in yeast and mammalian cells are highly conserved.
 
Introduction
 
Protein phosphatase 2A (PP2A),* one of the major protein
serine/threonine phosphatases in the cell, plays a role in sev-
eral cellular processes, including metabolism, transcription,
RNA splicing, translation, cell cycle progression, morpho-
genesis, signal transduction, development, and transforma-
tion (Mumby and Walter, 1993; Wera and Hemmings,
1995)
 
. 
 
The predominant form of PP2A in cells is a heterotri-
mer consisting of three subunits. The 36-kD catalytic C
subunit and the 63-kD regulatory A subunit (PR65) form
the core enzyme, and the B subunit binds the core enzyme
to form the holoenzyme. The A and C subunits both exist as
two isoforms (
 
 
 
 and 
 
 
 
), which are closely related, whereas
the B subunit is variable and its multiple isoforms belong to
at least three unrelated gene families, B/B55/PR55, B
 
 
 
/B56/
PR61, and B
 
 
 
/PR72/PR130 (Kamibayashi et al., 1994; Mc-
Cright and Virshup, 1995; Csortos et al., 1996). The cellu-
lar B subunits can also be replaced by viral proteins, such as
the SV40 small t antigen and the polyomavirus small and
middle T antigens (Mumby, 1995).
 
In 
 
Saccharomyces cerevisiae
 
, two closely related genes, 
 
PPH21
 
and 
 
PPH22
 
, redundantly encode the major PP2A catalytic
subunit (Sneddon et al., 1990). 
 
TPD3
 
 encodes the only A
subunit, and two distinct B subunits, encoded by 
 
CDC55
 
and 
 
RTS1
 
, are homologous to mammalian B and B
 
 
 
, respec-
tively (Healy et al., 1991; van Zyl et al., 1992; Shu et al.,
1997). Mutation of both 
 
PPH21
 
 and 
 
PPH22
 
 eliminates most
of the PP2A activity in the cell and drastically reduces growth.
Strains lacking 
 
PPH21
 
, 
 
PPH22
 
, and a third related gene,
 
PPH3
 
, are completely inviable (Ronne et al., 1991). Two
other PP2A-like phosphatase catalytic subunits exist, encoded
by 
 
SIT4
 
 (Sutton et al., 1991) and 
 
PPG1 
 
(Posas et al., 1993),
which perform nonredundant functions in the cells.
Mutations of 
 
CDC55
 
 yield defects in cytokinesis and re-
sult in abnormal cell morphology at low temperature,
whereas mutation of 
 
RTS1
 
 results in growth defects at high
temperature (Healy et al., 1991; Shu et al., 1997). PP2A was
proposed to play a role in activation of Clb–Cdc28 kinase
complexes for progression from G2 to mitosis (Lin and
Arndt, 1995). The effect of Cdc55 on cellular morphogene-
sis is also mediated through Cdc28, and it was proposed that
PP2A, regulated by Cdc55, affects the activity of the Cdc28
regulators Mih1 and Swe1 (Minshull et al., 1996; Wang and
Burke, 1997; Yang et al., 2000). 
 
CDC55
 
 was also implicated
 
as a component of the spindle checkpoint pathway: 
 
cdc55
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mutants are nocodazole sensitive (Wang and Burke, 1997),
and in the presence of a defective spindle, Cdc55-deficient
cells are still able to separate their sister chromatids and to
leave mitosis even though cyclin B destruction is prevented,
possibly by promoting inactivation of Cdc28 through inhib-
itory phosphorylation (Minshull et al., 1996).
Adenovirus early region 4 open reading frame 4 (E4orf4)
protein is a multifunctional viral regulator. Our work, as well
as work from other laboratories, has shown that the E4orf4
protein downregulates expression of genes that have been ac-
tivated by E1A and cAMP (Müller et al., 1992; Kleinberger
and Shenk, 1993), induces hypophosphorylation of various
viral and cellular proteins (Müller et al., 1992; Kanopka et al.,
1998), regulates alternative splicing of adenovirus mRNAs
(Kanopka et al., 1998), and induces p53-independent apop-
tosis in transformed cells (Lavoie et al., 1998; Marcellus et al.,
1998; Shtrichman and Kleinberger, 1998). Induction of
apoptosis has been reported to be caspase independent in
CHO cells (Lavoie et al., 1998), but it is caspase dependent in
293T cells (Livne et al., 2001). We have previously shown
that E4orf4 interacts with the PP2A holoenzyme through a
direct association with the B
 
 
 
/B55 subunit (Kleinberger and
Shenk, 1993). Interaction with PP2A complexes that include
the B
 
 
 
/B55 subunit is required for induction of apoptosis by
E4orf4 (Shtrichman et al., 1999). The presence of an active
PP2A also contributes to other functions performed by the
E4orf4 protein, including down regulation of transcription
(Kleinberger and Shenk, 1993; Bondesson et al., 1996;
Whalen et al., 1997) and alternative splicing (Kanopka et al.,
1998). Recently, we demonstrated that E4orf4 associates not
only with PP2A-B
 
 
 
, but also with several isoforms of PP2A-
B
 
 
 
. However, only the interaction of E4orf4 with a PP2A ho-
loenzyme population that includes the B
 
 
 
 subunit is required
for induction of apoptosis (Shtrichman et al., 2000).
A key unresolved question is the identity of the targets of
the PP2A-B
 
 
 
–E4orf4 complex involved in induction of
apoptosis. To gain insight into the cellular pathway induced
by the PP2A-B
 
 
 
–E4orf4 complex, we expressed E4orf4 in
the yeast 
 
S. cerevisiae
 
. Although yeast do not possess some of
the cellular machinery required for the apoptotic process,
such as caspases and Bcl-2 family members, this organism
can serve as a powerful tool for apoptosis research (Mat-
suyama et al., 1999). Here, we report that in yeast, expres-
sion of E4orf4 induces irreversible growth arrest through a
mechanism that requires Cdc55 and Tpd3, the yeast homo-
logues of the B and A subunits of PP2A. The cells arrested in
mitosis and exhibited enhanced accumulation of reactive ox-
ygen species (ROS), a feature of apoptosis in metazoan cells.
Our data suggest that E4orf4 acts via modulation of the
activity of the anaphase-promoting complex/cyclosome
(APC/C) ubiquitination complex. Furthermore, we show
that E4orf4 can induce G
 
2
 
/M arrest before apoptosis in
mammalian cells, suggesting that E4orf4-induced events are
conserved in yeast and mammals.
 
Results
 
E4orf4 induces irreversible growth arrest in yeast
 
Since E4orf4 binds the PP2A-B subunit, and yeast and
mammalian PP2A-B subunits share an extensive homology
(53% identity and 67% similarity) (Healy et al., 1991), we
tested whether expression of E4orf4 may affect yeast cell
growth in a PP2A-dependent manner. Wild-type E4orf4
and the A3 mutant, which did not bind an active PP2A and
did not induce apoptosis in mammalian cells (Shtrichman et
al., 1999), were cloned in a yeast vector under the control of
the 
 
GAL1,10
 
 promoter. On galactose plates, expression of
E4orf4, but not of mutant A3, prevented yeast growth,
 
whereas no growth defect was apparent on 
 
GAL1,10
 
-
repressing glucose plates (Fig. 1 A). This growth inhibition
depended on Cdc55, because in a 
 
cdc55
 
 
 
 strain, growth was
unaffected by E4orf4 (Fig. 1 B). Reintroduction of the
 
CDC55
 
 gene into the 
 
cdc55
 
 
 
 strain reinstated E4orf4-
induced toxicity in these cells (Fig. 1 B). A yeast strain lack-
ing the 
 
RTS1
 
 gene did not lose the ability to respond to
E4orf4 (Fig. 1 C), indicating that, as in mammalian cells,
Cdc55/B but not Rts1/B
 
 
 
, is required for E4orf4-induced
toxicity. Deletion of the 
 
TPD3
 
 gene, homologous to mam-
malian PP2A-A, also resulted in loss of the cellular response
to E4orf4 (Fig. 1 D). The altered response to E4orf4 did not
result from changes in levels of E4orf4 expression (Fig. 1 E).
The E4orf4-expressing plasmid was introduced into yeast
strains lacking each of the PP2A-like catalytic subunits:
Pph21, Pph22, Pph3, Sit4, and Ppg1. Each of these deletion
strains maintained the response to E4orf4 expression (Table
I), suggesting a redundancy in the catalytic subunit required
for the response to E4orf4.
We next investigated whether the E4orf4-induced growth
arrest was reversible. E4orf4 expression was induced by ga-
lactose in liquid medium, and growth was monitored by a
general count using a hemacytometer, and by a viable count.
Fig. 2 A shows that until 6 h after induction there was no
change in the apparent growth rate of cells expressing
E4orf4 versus control cells. However, at later times, E4orf4-
expressing cells showed a slower growth and stopped grow-
ing by 10 h after induction. If the cells were diluted to 3
 
  
 
10
 
6
 
 cells/ml in fresh galactose-containing medium at that
time, the E4orf4-containing cells did not regain exponential
growth, whereas control cells did (Fig. 2 B). Residual cell
growth seen at late time after E4orf4 induction may reflect
selection in liquid medium of cells carrying fewer copies of
the multicopy 2
 
 
 
 plasmid and expressing less E4orf4. In-
deed, Western blot analysis indicated that at 24 and 48 h af-
ter induction, E4orf4 levels in the population were lower,
compared with 3 and 6 h after induction (results not
shown). When E4orf4-expressing cells were transferred to
glucose medium, the 
 
GAL
 
 promoter was shut off and E4orf4
protein levels decreased (results not shown). Nonetheless,
cell viability, measured as the ability to produce colonies on
glucose plates, dropped rapidly within a few hours of growth
in the galactose-containing medium (Fig. 2 C). These results
indicate that E4orf4-induced growth arrest is irreversible.
It has been reported that cell death induced in yeast by
mammalian proapoptotic genes, such as Bax, is accompa-
nied by changes in cell membranes and DNA degradation,
typical of mammalian apoptosis (Zha et al., 1996). We
tested whether E4orf4 induced similar changes. However,
no alterations in trypan blue exclusion were observed at sev-
eral time points after induction of E4orf4 expression, and no
 
DNA degradation was detected on agarose gels as late as
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48 h after induction (results not shown). Furthermore, it has
been previously reported that Bax induction in yeast inhib-
ited cell growth in all cells, but it did not lead to death in
cells lacking functional mitochondria (petite) (Greenhalf et
al., 1996). We investigated whether E4orf4 expression in pe-
tite (
 
rho-0
 
) cells resulted in cell death, measured by colony
formation. E4orf4 was expressed from a tetracyclin-regulat-
able promoter (Gari et al., 1997), since petite cells did not
grow well on galactose. E4orf4 induction by doxycycline re-
moval was slower compared with its induction by galactose,
and 6 h after induction, its expression reached levels compa-
rable to those seen upon galactose induction 3 h after induc-
tion (results not shown). Cells were replated on plates con-
taining doxycycline at various times after induction. Fig. 2
D shows that loss of viability upon induction of E4orf4 was
similar in wild type and in petite yeast cells. The toxic effect
appeared later than with galactose-induced E4orf4, probably
due to the slower rate of E4orf4 induction by doxycycline
removal. Thus, this experiment demonstrates that E4orf4-
induced toxicity is independent of functions encoded by mi-
tochondrial DNA. The cellular events induced by E4orf4
appear to differ from those induced by Bax expression.
 
E4orf4 enhances cellular ROS levels
 
It has been recently reported that generation and accumula-
tion of oxygen radicals is a key event in apoptotic pathways
 
both in yeast and in mammalian cells (Hockenbery et al.,
1993; Kane et al., 1993; Slater et al., 1995; Madeo et al.,
1999). We tested whether E4orf4 induced enhanced ROS
levels in yeast cells. E4orf4 expression was induced with ga-
lactose for 6 h, and cells were then stained with 1 
 
 
 
g/ml di-
hydroethidium for 10 min. Dihydroethidium is oxidized
specifically by superoxide ions to fluorescent ethidium
(Budd et al., 1997). Fig. 3 (left) shows an example of
E4orf4-expressing cells, which accumulated ROS, as com-
pared with control cells. Fluorescence levels in the cells were
measured by FACS
 
®
 
 analysis, and Fig. 3 (right) demon-
strates that 26% of E4orf4-expressing cells were stained
above background levels, whereas only 3.3% of vector-con-
taining cells fluoresced above background. Staining with di-
hydrorhodamine 123, a compound that is oxidized to the
fluorescent chromophore rhodamine 123 by ROS (Schultz
et al., 1996), led to similar results (data not shown).
 
E4orf4 induces G
 
2
 
/M arrest
 
Microscopic examination of cells expressing E4orf4 showed
striking morphological changes: 8 h after induction, cells
were greatly enlarged, and many displayed abnormal buds.
To determine whether E4orf4 affects the cell cycle, DNA
content of cells expressing E4orf4 from the 
 
GAL
 
 promoter
was analyzed by FACS
 
®
 
. Fig. 4 A shows that within 4.5 h of
galactose induction, E4orf4-expressing cells started to accu-
Figure 1. E4orf4 inhibits growth in S. 
cerevisiae in a PP2A-dependent manner. 
W303 cells (A) or mutant cells (B–D) 
transformed with the indicated plasmids 
were plated on galactose (B–D) or on 
glucose versus galactose (A) and al-
lowed to grow for 2 d. (E) Proteins were 
prepared from the yeast cells used in
A–D, and E4orf4 levels were analyzed 
by Western blot. A3, the E4orf4 A3 mu-
tant.
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mulate in G
 
2
 
/M. To determine at what stage of mitosis the
cells arrested, we visualized the spindles with green fluores-
cent protein (GFP)–tubulin. Fig. 4 B shows that cells were ar-
rested at several mitotic stages. Most cells were arrested either
with short preanaphase spindles, or with extended telophase
spindles (49 and 40%, respectively;
 
 n 
 
  
 
100). Some of these
cells had undergone a second round of budding. After longer
induction times, chains of unseparated buds became visible,
and anucleated cells started to accumulate (not shown).
 
E4orf4 expression is synthetically lethal 
with reduction in Cdc28 activity
 
To pinpoint the cell cycle target of E4orf4, specific cell cycle
mutants were assayed for synthetic effects with E4orf4 ex-
pression. To that end, an alternative expression vector was
used, expressing lower levels of E4orf4 upon galactose in-
duction (pDAD-E4orf4). Comparison between levels of
E4orf4 expression from the pDAD and p426-GalL vectors is
shown in Fig. 5 A. When pDAD-E4orf4 was introduced
into wild-type yeast cells, only a weak effect on yeast growth
was detected, manifested by a slightly smaller colony size,
compared with control cells (Fig. 5 B). However, mutants of
the main yeast cell cycle kinase, Cdc28, were significantly
more sensitive to E4orf4 expression. Temperature-sensitive
 
CDC28
 
 mutants, such as 
 
cdc28-4
 
 and 
 
cdc28-1N
 
 (Surana et
al., 1991), as well as a mitotic cyclin–defective strain (
 
clb1
 
 
 
clb2ts clb3
 
 
 
 clb4
 
 
 
), were unable to grow even in the pres-
ence of the low levels of E4orf4 expressed from the pDAD
vector (Table I). In contrast, cell cycle mutants specifically
affected in the G
 
1
 
/S transition, such as 
 
cdc34
 
 or 
 
cdc53
 
, or
mutants affected in mitotic exit, such as 
 
cdc15
 
 or 
 
sic1
 
 
 
, were
not supersensitive to E4orf4 (Table I), confirming that
E4orf4 acts specifically at mitosis. The kinase Swe1 (the 
 
S
 
.
 
cerevisiae
 
 homologue of mammalian Wee1) and the phos-
phatase Mih1 (the 
 
S
 
.
 
 cerevisiae
 
 homologue of Cdc25), re-
spectively, inhibit and activate Cdc28 activity (Russell et al.,
1989; Booher et al., 1993). 
 
mih1
 
 
 
 cells were more sensitive
to E4orf4 expression (Fig. 5 B), and overexpression of Swe1
was synthetically lethal with E4orf4 expression (Table I),
suggesting that E4orf4 may act via activation of the inhibi-
tory kinase Swe1. However, deletion of 
 
SWE1 
 
did not sup-
press the toxicity of E4orf4 (Table I). Furthermore, al-
though Swe1 and Mih1 both act on Tyr19 of Cdc28,
expression of the constitutively active Cdc28-F19 mutant in
wild-type cells did not suppress the toxicity of E4orf4 (Table
I), suggesting that in these cells the mechanism of action of
E4orf4 does not involve modulation of phosphorylation of
Cdc28 on Tyr19.
To further investigate the E4orf4 effect on Cdc28 activity,
Cdc28-Clb2 kinase activity was compared in cells contain-
ing p426-GalL-E4orf4 or the empty vector 6 h after induc-
tion with galactose. As seen in Fig. 5 C, enhanced kinase ac-
 
Table I. 
 
Growth of various yeast mutants 
in the presence of E4orf4
 
Yeast strain Plasmid
p426-GalL-E4orf4 pDAD-E4orf4
 
W303
 
    
 
cdc55
 
     
 
ND
 
cdc55
 
 
 
 
 
 
 
ADH-CDC55
 
  
 
  
 
rts1
 
  
 
ND
 
cdc55
 
 
 
 rts1
 
     
 
ND
 
tpd3
 
     
 
ND
 
pph21
 
  
 
ND
 
pph22
 
  
 
ND
 
pph3
 
  
 
ND
 
sit4-36
 
-N D
 
ppg1
 
  
 
ND
 
cdc28-4
 
ND
 
 
 
cdc28-1N
 
ND  
clb1  clb2-v1 clb3  clb4  ND  
mih1  ND  
swe1      
W303  GAL-SWE1   ND  
swe1  mih1      
CDC28F19     
cdc34-2 ND   
cdc53-1 ND   
cdc15-2 ND   
sic1  ND   
cdc20-1 ND  
cdh1  ND  
pds1      
cdc16-1 ND  
CDC16-6A CDC23-A CDC27-5A   ND
mad1   ND
mad2   ND
mad3   ND
bub1      
bub2   ND
Figure 2. E4orf4-induced growth arrest is irreversible and occurs 
both in wild-type and rho-0 yeast cells.  , cells containing vector 
plasmid;  , cells expressing E4orf4. (A) Cells were transferred from 
raffinose to galactose at time 0. Aliquots were collected at various 
time points after induction, and cells were counted microscopically. 
(B) The experiment was done as in A, but at 9 and 24 h after induc-
tion cells were diluted to 3   10
6/ml in medium containing galac-
tose and allowed to continue growing. (C) At the time points shown 
in A, 1,000 cells were plated on glucose plates. Colonies were 
counted after 2 d, and the number of colonies at time 0 was defined 
as 100%. (D) A similar experiment as described in C was per-
formed, except a doxycycline-regulatable promoter was used, 
E4orf4 expression was induced by removal of doxycycline at time 0, 
and rho-0 cells (  and  ) were compared with wild-type cells (  
and  ). Every experiment shown is one of a series of three that 
yielded similar results.
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tivity was observed in wild-type cells in the presence of
E4orf4, whereas no differences in kinase activity were seen
in an mih1  mutant. The levels of Clb2 protein were similar
in control cells and in cells expressing E4orf4 (Fig. 5 D).
These results indicate that E4orf4 expression leads to an
Mih1-dependent increase in specific Cdc28-Clb2 kinase ac-
tivity. Thus, the hyperactivation of Cdc28 by E4orf4 may be
a secondary E4orf4 effect that partially counteracts the main
E4orf4 inhibitory effect on cell cycle progression. The in-
ability of the mih1  strain to hyperactivate Cdc28 by Tyr19
dephosphorylation might explain its supersensitivity to
E4orf4. To test this hypothesis, the nonphosphorylatable
Cdc28-A18F19 mutant was introduced in the mih1  strain.
The resulting strain reverted to a level of E4orf4 sensitivity
similar to the wild-type strain (Fig. 5 E), indicating that in-
ability to dephosphorylate Cdc28 is the reason for the hy-
persensitivity of the mih1  mutant to E4orf4.
E4orf4-expressing cells are supersensitive to benomyl
Cdc55 has been identified as a component of the spindle as-
sembly checkpoint (Wang and Burke, 1997). Mutations in
genes that affect the kinetochore/spindle checkpoint result
in cells that are more sensitive to the microtubule-depoly-
merizing drug benomyl than wild-type cells, and deletion of
CDC55 causes enhanced benomyl sensitivity (Minshull et
al., 1996; Wang and Burke, 1997). We tested whether
E4orf4 affects benomyl sensitivity of cells. Yeast cells ex-
pressing E4orf4, mutant A3, or the empty vector were seri-
Figure 3. ROS accumulate in E4orf4-
expressing cells. Cells carrying pGalL-
E4orf4 or the vector plasmid were grown 
for 6 h in galactose medium and were 
then stained for 10 min with 1  g/ml di-
hydroethidium (DHE). Fluorescence was 
visualized through a rhodamine filter on 
a Zeiss Axioscop, at a magnification of 
600 . The proportion of dihydroxy-
ethidium-stained cells was measured by 
FACS
® analysis (right).
Figure 4. E4orf4-expressing cells accu-
mulate in different stages of mitosis. (A) 
Cells carrying either the p426GalL-
E4orf4 plasmid or the p426GalL vector 
were grown to midlog phase in glucose, 
washed once, and resuspended in galac-
tose. Samples were removed every 90 
min after induction by galactose, and 
cellular DNA content was measured by 
FACS
® analysis. (B) Cells expressing a 
GFP–Tub1 fusion, and carrying either
the p426GalL-E4orf4 plasmid or the 
p426GalL vector, were induced with ga-
lactose for 8 h. Cells were harvested, 
fixed with 4% paraformaldehyde, stained 
with DAPI, and visualized by light mi-
croscopy (left), by fluorescence in the 
DAPI channel (middle), or in the FITC 
channel to detect GFP–tubulin fluores-
cence (right) at a 1,000  magnification.
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ally diluted and plated on galactose plates containing suble-
thal concentrations of benomyl. Fig. 6 shows that cells
expressing low E4orf4 levels are highly sensitive to benomyl,
compared with control cells. Cells that express mutant
E4orf4 (A3), even at high levels, are no more sensitive to
benomyl than are the control cells. Thus, E4orf4, through its
interaction with PP2A, may functionally interact with the
spindle assembly checkpoint, or it may directly inhibit the
target of this checkpoint. Several yeast strains containing mu-
tations in genes involved in spindle checkpoint control were
tested for a synthetic effect with E4orf4. However, these
genes, including MAD1, -2, -3 and Bub1 and -2 did not
manifest such an effect in the absence of benomyl (Table I).
The APC/C is a target of the E4orf4 pathway
The APC/C ubiquitination complex is required, with its
Cdc20 subunit, for the metaphase-to-anaphase transition,
and with another subunit, Hct1/Cdh1, it is involved in mi-
totic exit. We found that APC/C mutants, as well as the
cdc20-1 and cdc20-3 mutants, and the cdh1/hct1 deletion,
are supersensitive to E4orf4 (Table I). It was reported that
the exit from mitosis involves a biphasic inactivation of the
Cdc28-Clb2 kinase and degradation of Clb2. The first phase
is dependent on Cdc20 and starts at the metaphase-to-ana-
phase transition. The second phase occurs in telophase and
requires activation of the Cdc20 homologue, Hct1/Cdh1
(Visintin et al., 1997; Baumer et al., 2000; Yeong et al.,
2000). To characterize the effect of E4orf4 on APC/C activ-
ity, we followed accumulation and degradation of substrates
of both APC/C complexes. To measure degradation rates by
APC/C
Cdh1, the substrate Ase1 was used, since APC
Cdh1 ac-
tivity is highest in G1, and ectopic Clb2 expression was in-
compatible with maintenance of G1 arrest (Juang et al.,
1997; Visintin et al., 1997). As shown in Fig. 7 A, Ase1 was
Figure 5. Functional interaction of 
E4orf4 with Mih1. (A) To compare 
E4orf4 expression levels from the pDAD 
and p426-GalL vectors, cells were in-
duced with galactose for 3 h, and E4orf4 
levels were determined by Western blot. 
(B) Wild-type or mih1  cells carrying the 
indicated plasmids were grown on ga-
lactose plates for 2 d. (C) KY630 (MIH1) 
or KY631 (mih1 ) cells carrying a CLB2-
3xHA construct integrated at CLB2 and 
transformed with either vector or 
p426GalL-E4orf4 were induced for 6 h 
with galactose. Clb2-associated kinase 
activity in the extracts was determined 
using Histone H1 as substrate. The 
amount of Histone H1 phosphorylation 
was measured with a phosphorimager. 
(D) Clb2-3xHA levels in the extracts de-
scribed in C were determined by West-
ern blotting. C, a no tag control; G1, an 
extract of CLB2-3xHA-expressing mutant 
cells arrested at restrictive temperature 
in G1. (E) MIH1 and mih1  cells were 
transformed with the indicated plasmids, 
and serial dilutions were plated drop-
wise on galactose plates.
 
o
n
 
A
p
r
i
l
 
3
0
,
 
2
0
0
8
 
w
w
w
.
j
c
b
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 E4orf4 induces PP2A-dependent growth arrest in yeast | Kornitzer et al. 337
significantly stabilized in the presence of E4orf4, its half-life
increasing from 2.5 to 7 min. Pds1, an inhibitor of the
metaphase-to-anaphase transition, is degraded by APC
Cdc20
(Visintin et al., 1997). In E4orf4-expressing cells, Pds1 accu-
mulated to significantly higher levels than in control cells,
suggesting that Pds1 degradation is also inhibited by E4orf4
(Fig. 7 B). To directly assay the effect of E4orf4 on Pds1
degradation by pulse–chase, we artificially arrested the cells
with  -factor in G1, a cell cycle phase where Pds1 had been
shown to be unstable (Cohen-Fix et al., 1996). Under these
conditions, however, no difference was seen in Pds1 degra-
dation between control and E4orf4-expressing cells—in
both cases, Pds1 was degraded with a half-life of 3 min (re-
sults not shown). Since Pds1 degradation normally occurs at
the metaphase-to-anaphase transition, its ectopic degrada-
tion in G1-arrested cells may reflect an alternative mecha-
nism that is different from its normal mechanism of degra-
dation. Therefore, an attempt was made to arrest the cells in
metaphase by expressing nondegradable Pds1 (Cohen-Fix
and Koshland, 1999). However, cell cycle arrest could not
be maintained during the relatively long period of time re-
quired for E4orf4 accumulation. Thus, we could not reliably
determine directly the effect of E4orf4 on Pds1 stability.
E4orf4 physically interacts with the APC/C 
and recruits PP2A to the complex
One possibility for explaining the effect of E4orf4 on APC/
C activity is that it directly targets PP2A to the APC/C. We
tested this hypothesis by assaying whether E4orf4 physically
interacts with the APC/C. HA-tagged Cdc16 was expressed
in E4orf4 (wild type or the A3 mutant)–expressing versus
control cells, and cell extracts were prepared 5 h after induc-
tion with galactose. E4orf4 was immunoprecipitated from
the various samples, and the presence of the HA-tagged
APC/C subunit Cdc16 in the immune complexes was
detected by Western blot analysis. Fig. 8 A demonstrates
that wild-type E4orf4 coimmunoprecipitated with Cdc16,
whereas the A3 mutant associated with HA-Cdc16 more
weakly. The A3 mutant did not bind Tpd3 at all, similar to
our findings in mammalian cells (Shtrichman et al., 2000).
No HA-Cdc16 was immunoprecipitated in the absence of
E4orf4 proteins. These results indicate that E4orf4 specifi-
cally associates with APC/C in yeast cells. We next tested
whether E4orf4 expression leads to enhanced recruitment of
PP2A to the APC/C. HA-Cdc16 was expressed in wild-type
yeast cells or in tpd3  cells, with wild-type E4orf4 or with
the empty vector. Immunoprecipitation reactions were car-
ried out with antibodies to Tpd3, and the presence of HA-
Cdc16 in the immune complexes was detected by a Western
blot. Fig. 8 B demonstrates that Cdc16 was present in a
complex with PP2A in cell extracts expressing E4orf4. No
interaction above background levels, determined by a similar
immunoprecipitation from tpd3  cell extracts, was detected
in the absence of E4orf4. These results could suggest that in
the absence of E4orf4, PP2A and the APC/C do not inter-
act; alternatively, PP2A and the APC/C may normally inter-
act, but this interaction may be too weak to be detected by
immunoprecipitation in the absence of E4orf4.
To test for functional interactions between PP2A and
the APC/C, the pADH-CDC55 plasmid, overexpressing
Cdc55, was transformed into wild-type yeast cells or into
cdc20-1 cells. As seen in Fig. 8 C, although wild-type cells
were efficiently transformed with the pADH-CDC55 plas-
mid, no transformants were obtained in the cdc20-1 back-
ground, suggesting that increased PP2A-Cdc55 activity is le-
thal in this background. Conversely, it has been previously
reported that deletion of CDC55 partially suppresses the
temperature sensitivity of the cdc20-1 mutant (Wang and
Burke, 1997). Together, these data suggest that even in the
absence of E4orf4, PP2A-Cdc55 acts as a negative regulator
of the APC/C
Cdc20. Thus, the results presented in Fig. 8 sug-
gest that E4orf4 may be merely stabilizing an existing inter-
action between these two protein complexes.
E4orf4 can induce G2/M arrest in mammalian cells
The work presented here demonstrated that yeast cells ex-
pressing E4orf4 accumulated in G2/M, whereas previous
work in mammalian cells indicated that E4orf4 expression
led to apoptosis. Upon transient transfection of E4orf4 into
various mammalian cell lines, no cell cycle effects were de-
tected. However, in a stably transfected 293-derived cell
line, expressing E4orf4 from a tetracycline-regulated pro-
moter, G2/M arrest was observed 24 h after induction with
doxycycline (Fig. 9). No such arrest was observed upon
treatment of a parallel control cell line. 48 h after induction,
the G2/M arrest was released, and cells with sub-G1 DNA
content undergoing apoptosis started to accumulate. These
results indicate that, under certain physiological conditions,
E4orf4 can initially induce cell cycle arrest, from which the
cells eventually escape and undergo apoptosis.
Discussion
In this work, we showed that adenovirus E4orf4, which in-
duces apoptosis in transformed mammalian cells through a
mechanism involving its interaction with PP2A complexes
containing the B, but not the B  subunit, causes irreversible
growth arrest in S. cerevisiae. This growth arrest requires
yeast PP2A complexes containing Cdc55, but not Rts1, and
occurs at a specific cell cycle stage. These observations, and
our recent findings indicating that nontoxic E4orf4 mutants
selected in yeast could not induce apoptosis in mammalian
cells (Afifi et al., 2001), underscore the high conservation of
the E4orf4 targets between yeast and mammalian cells.
Thus, as a first step towards elucidating the E4orf4-induced
apoptotic pathway in mammalian cells, we took advantage
Figure 6. E4orf4-expressing cells are supersensitive to benomyl. 
Cells expressing low levels (pDAD-E4orf4) or high levels (p426-
GalL-E4orf4) of E4orf4 or the E4orf4A3 mutant were grown in liquid 
medium containing glucose, serially diluted, and grown on galac-
tose-containing plates, with or without 15  g/ml benomyl, for 2 d.
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of the wealth of available yeast cell cycle mutants to map the
interaction of E4orf4 with the yeast cell cycle machinery.
Genetic interactions between E4orf4 and Cdc28
Genetic interactions suggested that reducing the activity of
the Cdc28 kinase resulted in hypersensitivity to E4orf4.
Thus, the growth arrest was more severe in cdc28 or mitotic
cyclin mutants, and in mutants lacking the activating Mih1
phosphatase or overexpressing the inhibitory Swe1 kinase
(Fig. 5; Table I). Absence of the Swe1 kinase, or of the Swe1
target on Cdc28 (Cdc28-F19) did not affect sensitivity to
E4orf4. Strikingly however, in the presence of E4orf4, Clb2-
associated kinase was hyperactivated in an Mih1-dependent
manner (Fig. 5). Thus, E4orf4 may partially counteract its
own cell cycle inhibitory effect by stimulating dephosphory-
lation of Cdc28-Y19 by Mih1. The hypersensitivity of the
mih1 mutant would be due to its inability to respond to this
stimulation. Indeed, the hypersensitivity was overcome by
expression of a constitutively active Cdc28-A18F19 mutant
in the mih1  cells (Fig. 5 E).
E4orf4 inhibits APC/C activity
Morphologically, E4orf4-arrested cells appear to be in pre-
anaphase and telophase stages (Fig. 4) in wild type, as well as
in mih1  cells, however the proportion of short preanaphase
spindles was higher in the mih1  mutant (data not shown).
Biochemical examination of the E4orf4-expressing cells in-
dicates that they are defective in Ase1 degradation and accu-
mulate high levels of Pds1 as well (Fig. 7). These results sug-
gest that E4orf4 specifically inhibits APC
Cdh1 and may also
inhibit APC
Cdc20. This is supported by the hypersensitivity
of both cdc20ts mutants and cdh1  mutants to E4orf4, as
well as by the dual morphology of the arrested cells. The lack
of an effect of E4orf4 on Pds1 degradation in G1-arrested
cells does not support an inhibition of APC
Cdc20; however,
whereas Pds1 degradation normally occurs at the metaphase-
to-anaphase transition, it could for technical reasons only be
assayed in G1-arrested cells (Visintin et al., 1997). Thus, it
is possible that under these artificial conditions, the effect of
E4orf4 on APC
Cdc20 activity is lost. An arrest of the cells in
metaphase by expression of a nondegradable Pds1 is tran-
sient (Cohen-Fix and Koshland, 1999) and does not provide
enough time for optimal E4orf4 expression. In any case, it
should also be noted that since pds1  cells are still sensitive
to E4orf4 (Table I), there must be another substrate of
APC
Cdc20 that is required for E4orf4-induced arrest. The su-
persensitivity of E4orf4-expressing cells to benomyl (Fig. 6)
is also best explained by inhibition of APC
Cdc20. Benomyl,
which transiently triggers the spindle assembly checkpoint
by inhibiting APC
Cdc20 (Fang et al., 1998; Hwang et al.,
1998), might cause permanent arrest when the APC is al-
ready partially inhibited.
E4orf4 targets PP2A to the APC/C
The observations that E4orf4 coimmunoprecipitates with
APC/C subunits and that PP2A associates with the APC/C
in E4orf4-expressing cells (Fig. 8) suggest that E4orf4 func-
tions by directly targeting PP2A to the APC/C. Several yeast
APC/C subunits were shown to be phosphorylated (Peters et
al., 1996). Furthermore, phosphorylation of the APC/C by
Cdk1 was shown to be required for its activation both in
metazoans (Lahav-Baratz et al., 1995; Shteinberg et al.,
1999) and in yeast (Rudner and Murray, 2000), either di-
rectly or indirectly via activation of the Cdc5/Polo kinase
Figure 7. Effect of E4orf4 on degrada-
tion of APC/C substrates. (A) Degrada-
tion of Ase1-3xMyc in cells expressing 
E4orf4 from the p426-GalL-E4orf4 plas-
mid was measured by pulse–chase anal-
ysis. Cells arrested in G1 with  -factor 
were induced for 6 h with galactose. 
FACS
® analysis of the cell population at 
the time of the chase indicates that the 
G1 arrest was maintained throughout 
the induction. The graph shows the re-
sult of the quantitation of the Ase1 band 
by phosphorimager. (B) Accumulation of 
Pds1-3xMyc in control versus p426-
GalL-E4orf4–containing cells was mea-
sured by Western blotting after 6 h of ga-
lactose induction. Cells arrested by no-
codazole (NOC) served as control.
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(Charles et al., 1998). Thus, E4orf4 may inhibit the APC by
inducing its dephosphorylation by PP2A. We suggest that
APC/C activity in E4orf4-expressing cells results from the
net effect of phosphorylation by Cdc28 and dephosphoryla-
tion by E4orf4/PP2A. Therefore, mutants having reduced
Cdc28 activity are hypersensitive to E4orf4. This model is
summarized in Fig. 10.
The identity of the specific phosphorylation sites on the
APC/C targeted by E4orf4 still eludes us. It appears that
the phosphorylation sites described previously in Cdc16,
Cdc23, and Cdc27 (Rudner and Murray, 2000) are not the
substrates of the E4orf4–PP2A complex, since substitution
of these sites to alanine residues has only a weak effect on
APC/C function (Rudner and Murray, 2000), and do not
render the yeast cells resistant to E4orf4 toxicity (Table I).
Furthermore, although it was reported that APC/C phos-
phorylation at these sites affects only the activity of the
APC/C
Cdc20 complex (Rudner et al., 2000), our results sug-
gest that E4orf4, through its association with both PP2A
and the APC/C, affects the APC/C
Cdh1 complex as well. It
should be noted that Cdh1 itself is activated, rather than re-
pressed, by dephosphorylation; however, this dephosphory-
lation is carried out by a distinct phosphatase, Cdc14 (Visin-
tin et al., 1998; Zachariae et al., 1998).
The inhibitory effect of PP2A on APC/C activity in the
presence of E4orf4 could represent a novel interaction in-
duced by the viral protein; alternatively, E4orf4 could be
merely enhancing a physiological interaction of PP2A with
the APC/C. We found that overexpression of Cdc55 was
synthetically lethal with the cdc20-1 mutation even in the
absence of E4orf4 (Fig. 8 C). Conversely, Wang and Burke
(1997) reported that deletion of CDC55 partially suppressed
the cdc20-1 temperature sensitivity. Therefore, we suggest
that one of the normal functions of PP2A is to inhibit the
APC/C. Deletion of the PP2A regulator CDC55 would re-
sult in derepression of APC/C activity, counterbalancing the
reduction of Cdc20 activity of the cdc20-1 mutant, thereby
resulting in suppression of the mutant phenotype. This may
also provide an additional explanation for the loss of spindle
assembly checkpoint activity detected in the cdc55  mutant
by Minshull et al. (1996). These authors attributed the loss
of the checkpoint to increased inhibitory phosphorylation of
Cdc28 on Tyr19. However, even in the presence of the
Cdc28-V18F19 mutant, a reduction in Clb2 levels, and a
concomitant reduction in Clb2-associated kinase activity,
was detectable in the cdc55  cells (Minshull et al., 1996).
Therefore, we suggest that derepression of APC/C activity in
the cdc55  mutant may additionally make inactivation of
the APC/C by the checkpoint pathway less effective, con-
tributing to loss of checkpoint activity.
The similarity between E4orf4-initiated pathways 
in yeast and mammalian cells
In a 293-derived cell line, E4orf4 induces G2/M arrest before
induction of apoptosis (Fig. 9). In a previous report, Wersto
et al. (1998) demonstrated that, in the absence of the E1 re-
gion of adenovirus, the E4 region of the virus (excluding
E4orf6) can induce G2 growth arrest and elevation in cyclins
A and B and p34
cdc2 kinase protein levels. The finding of ele-
vated levels of mitotic cyclins in E4-arrested mammalian
cells could result from interference with the degradation of
mitotic cyclins (Wersto et al., 1998). Thus, the similar effect
of E4orf4 on mammalian and yeast cells could reflect a con-
servation not only of the PP2A–E4orf4 interaction, but also
of the interaction of PP2A–E4orf4 with its target, the APC/
C. This possibility is currently being investigated. Many viral
proteins cause cell cycle dysregulation, either as their primary
function to create optimal conditions for viral replication, or
as a by-product of their primary function. However, whether
the effect of E4orf4 on the cell cycle reflects one of its natural
functions or whether it is a consequence of its ectopic expres-
sion outside the viral life cycle is not clear yet.
Figure 8. E4orf4 targets PP2A to the APC/C. (A) Cells expressing 
wild-type E4orf4 or the A3 mutant from the galactose-inducible pro-
moter, and HA-tagged Cdc16, were induced with galactose for 5 h. 
Proteins were immunoprecipitated with antibodies to E4orf4, and 
the presence of HA-Cdc16, Tpd3, and E4orf4 in the immune com-
plexes was detected by a Western blot. (B) W303 and tpd3  cells 
expressing wild-type E4orf4 and the HA-tagged Cdc16 were in-
duced as in A. Proteins were immunoprecipitated with antibodies to 
Tpd3, and the presence of HA-Cdc16 and Tpd3 in the immune 
complexes was detected by a Western blot. (C) CDC20 and cdc20-1 
cells were transformed with pADH-CDC55 or a vector plasmid and 
plated on SC-LEU to select for transformants.
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Our initial motivation in expressing E4orf4 in yeast was
to gain more information on the pathway of apoptosis in-
duction by E4orf4 in transformed mammalian cells. Al-
though apoptosis has mainly been described in multicellular
organisms, in recent years there have been several observa-
tions of apoptosis-like phenomena in unicellular eukaryotes,
including S. cerevisiae (Madeo et al., 1997). Despite the fact
that none of the genes involved in the basic apoptotic ma-
chinery in metazoans, such as Bcl-2 or caspases, were identi-
fied in yeast, introduction of proapoptotic genes, such as
BAX or BAK into yeast, resulted in cytotoxicity with apop-
totic-like phenotypes (Greenhalf et al., 1996; Zha et al.,
1996; Ink et al., 1997; Tao et al., 1997). Furthermore, the
generation of ROS plays a role in the apoptotic process both
in metazoans and in yeast (Hockenbery et al., 1993; Kane et
al., 1993; Slater et al., 1995; Madeo et al., 1999). Thus,
yeast has become a useful model system for the study of
parts of the apoptotic pathway (Matsuyama et al., 1999).
We found that yeast cells expressing E4orf4 irreversibly
stopped proliferating and exhibited one of the hallmarks of
apoptosis, namely, accumulation of ROS. E4orf4 expression
also leads to accumulation of ROS in mammalian cells.
However, this similarity in phenotype does not necessarily
reflect a similarity in mechanism, especially since yeast cells
lack the death receptor pathway that is recruited by E4orf4
in mammalian cells to induce ROS accumulation (Livne et
al., 2001). Other regulators shown to be involved in E4orf4-
induced apoptosis in mammalian cells are also lacking
in yeast, such as the Src family of kinases (Lavoie et al.,
2000). However, E4orf4 induces both caspase-dependent
and caspase-independent cell death pathways in mammalian
cells (Lavoie et al., 1998; Livne et al., 2001). The cell cycle
arrest induced by E4orf4 in yeast may be mechanistically rel-
evant to at least one of these two apoptotic pathways.
Perturbations in cell cycle regulation 
and induction of apoptosis
We found that in a 293-derived cell line, the E4orf4-
induced G2/M arrest is followed by apoptosis (Fig. 9). Several
compounds—PKC inhibitors (Begemann et al., 1998), taxol
(Jordan et al., 1996), and viral genes such as HIV-1 Vpr
(Stewart et al., 1997)—have been reported to induce both
G2/M arrest and apoptosis in mammalian cells. Conversely,
several reports demonstrated that induction of apoptosis by
various stimuli required CDC2 or CDK2 activity (Shi et al.,
1994; Meikrantz and Schlegel, 1996; Yao et al., 1996).
Thus, perturbations in cell cycle control can lead to apopto-
sis. Furthermore, a specific link between APC/C inhibition
and apoptosis has been previously established in a report
showing that the APC/C Cdc27 subunit was cleaved by
caspases in Jurkat cells induced to undergo apoptosis by Fas,
resulting in APC/C inhibition and cyclin A and B stabiliza-
tion (Zhou et al., 1998). CDC2 kinase activity was further
induced in these cells due to caspase cleavage and inactiva-
tion of Wee1, resulting in reduced tyrosine phosphorylation
at the inhibitory site. In these cells, similar to our findings in
yeast expressing E4orf4, the APC/C is inhibited and Cdks
are stimulated. It is possible that this combination of APC/C
inhibition and Cdk stimulation contributes to induction of
Figure 9. Induction of G2/M arrest in 
293 cells expressing E4orf4 from a tet-
racycline-inducible promoter. 293 cells 
expressing E4orf4 from a tetracycline-
inducible promoter (E4orf4-positive cell 
line) and control cells (E4orf4-negative 
cell line) were induced with increasing 
concentrations of doxycycline. FACS
® 
analysis was performed for each point.
Figure 10. A schematic model for the mechanism of E4orf4 inter-
ference with cell cycle regulation. APC/C activity in E4orf4-
expressing cells results from the net effect of activation by Cdc28 
and inactivation by E4orf4/PP2A (see text for details).
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the apoptotic process in mammalian cells, and that this is
one of the pathways through which E4orf4 selectively kills
transformed cells. This notion, which can now be tested di-
rectly, may eventually result in novel therapeutic strategies.
Materials and methods
Yeast strains, media, and mammalian cell lines
Yeast were grown either in YPD (1% yeast extract, 2% bacto peptone,
0.015% L-tryptophan, 2% glucose) or in synthetic complete medium (Sher-
man et al., 1982). For induction with galactose, cells were grown in syn-
thetic medium with 2% raffinose overnight. They were then diluted to A600
0.3 and allowed to grow another 2 h before addition of galactose to 2%.
Alternatively, cells were grown in 2% glucose to midlog phase, washed
once, and resuspended in 2% galactose. For induction by doxycycline re-
moval, cells were grown overnight in medium containing 2% glucose and
5  g/ml doxycycline. They were then diluted to A600 0.3 and allowed to
grow another 2 h in the same medium before being washed twice in water
and transferred to medium without doxycycline.
All yeast strains used in this study are listed in Table II, along with their
sources. All the strains are isogenic with strain W303. Derivation of a rho-0
strain was carried out as described (Sherman et al., 1982). Strain KY520
was built by crossing strain CY5580 (a, leu2, ura3, cdc55::LEU2) (Wang
and Burke, 1997) with W303. Similarly, KY679 was obtained by crossing
Y1366 (a, his3 1, lys2-1, leu2-3, 112 ura3-52, tpd3 ::LEU2) (van Zyl et
al., 1992) with W303. Strains KY596 and KY600 were obtained by trans-
formation with mih1::LEU2 (Russell et al., 1989) and swe1::LEU2 (Booher
et al., 1993) deletion plasmids, respectively. Strain KY620 was obtained by
crossing a swe1 ::LEU2 with a mih1 ::LEU2 strain. Presence of the two
markers was deduced from tetrad analysis and confirmed by backcross.
Strains KY630, KY631 were obtained by integrating the YiP CLB2-3xHA
plasmid (L. Johnston, National Institute for Medical Research, London, UK)
into the W303 and KY620 strains at CLB2.
A 293-derived cell line expressing E4orf4 from a tetracycline-inducible
promoter was prepared by introducing E4orf4 cDNA cloned in the
pUHG10-3 vector (Gossen and Bujard, 1992) and pBabe-Puro (Morgen-
stern and Land, 1990) into the 293 Tet-On cell line (CLONTECH Laborato-
ries) and selection for puromycine-resistant colonies. A cell line selected in
the same way but not expressing E4orf4 is used as a negative control.
Plasmids
E4orf4 and mutant A3 were subcloned into the BamHI-ClaI sites of pCM190
(Gari et al., 1997), into the BamHI-EcoRI sites of p414 GALL (Mumberg et
al., 1994), or into the BglII-EcoRI sites of pDAD2, a yeast 2  plasmid con-
taining the GAL1,10 promoter (Kornitzer et al., 1994). PDS1 was cloned by
PCR under the CUP1 promoter of plasmid KB354 (Meimoun et al., 2000)
and fused to the triple Myc epitope tag. Other plasmids have been previ-
ously described: YCp50-CDC55 (Nickels and Broach, 1996), pDB20(HA-
CDC55) (Zhao et al., 1997), GAL10:SweI (Booher et al., 1993), HA-Cdc16
(Hwang and Murray, 1997), GAL-Ase1-Mycx3 (Juang et al., 1997).
Detection of ROS accumulation
Free intracellular radicals were detected with dihydroethidium or with di-
hydrorhodamine 123 (Sigma-Aldrich). Dihydroethidium was added at 1
 g/ml of cell culture, and cells were viewed through a rhodamine optical
filter after a 10-min incubation. Dihydrorhodamine 123 was added at 5  g/
ml of cell culture, and cells were viewed through a rhodamine filter after a
2-hr incubation. For FACS
® analysis, cells were incubated with dihydroethid-
ium as described and analyzed using FACSCalibur
® (Becton Dickinson).
Histone H1 kinase assay
 3   10
8 cells treated as indicated were pelleted, washed once, resus-
pended in 0.1 ml extraction buffer (20 mM Tris-Cl, pH 7.5, 100 mM NaCl,
10 mM EDTA, 1% Triton X-100, 5% glycerol, 1 mM each of NaF, Na-pyro-
Table II. Yeast strains
Strain Genotype Reference or source
W303-1A a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 GAL  R. Rothstein
a
10131-7C a ura3-52 leu2-3 sit4-36 GAL  G. Fink
H314   ura3-1 leu2-3,112 trp1-1 ade2-1 pph22-d1::HIS3 Ronne et al., 1991
H339 ura3-1 leu2-3,112 trp1-1 ade2-1 pph3::LEU2 Ronne et al., 1991
H341 a ura3-1 leu2-3,112 trp1-1 ade2-1 pph21-d1::HIS3 Ronne et al., 1991
rts1-null   ura3-1 leu2-3,112 his3 trp1-1 rts1::HIS3 Shu et al., 1997 
rts1-null,cdc55-null   ura3-1 leu2-3,112 his3 trp1-1 rts1::HIS3 cdc55::TRP1 Shu et al., 1997
ppg1  a ura3-1 leu2-3,112 his3-11 trp1-1 ppg1::TRP1 Posas et al., 1993
K1989 a cdc28-4 ura3 trp1 K. Nasmyth
K1993 a cdc15-2 ura3 trp1 leu2 K. Nasmyth
A364 a cdc16-1 leu2 trp1 A. Amon
A368 a cdc28-1N ura3 leu2 trp1 A. Amon
A460 a cdc20-1 ura3 leu2 trp1 his3 A. Amon
A544 a clb1D clb3::TRP1 clb4::HIS3 clb2-v1(ts) ura3 A. Amon
A698 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 bar1D sic1::HIS3 A. Amon
W321 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 hct1D1::LEU2 Schwab et al., 1997
MTY670 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 cdc34-2 M. Tyers
b
MTY740 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 cdc53-1 M. Tyers
PS694   ura3-52 leu2 trp1-1 CDC28-F19::TRP1 P. Sorger
c
K7375 a pds1::URA3, ura3::URA3 tetOs, leu2::LEU2 tetR-GFP Alexandru et al., 1999
KH123 a ura3-52 leu2-3,112 trp1 can1 ade2 his3-11,15 mad1D1::HIS3 Hardwick and Murray, 1995
KH141 a ura3-52 leu2-3,112 trp1 can1 ade2 his3-11,15 mad2D::URA3 Hardwick and Murray, 1995
KH125 a ura3-52 leu2-3,112 trp1 can1 ade2 his3-11,15 mad3D1::LEU2 Hardwick and Murray, 1995
KH127 a ura3-52 leu2-3,112 trp1 can1 ade2 his3-11,15 bub1D::HIS3 Hardwick and Murray, 1995
KH128 a ura3-52 leu2-3,112 trp1 can1 ade2 his3-11,15 bub2D::URA3 Hardwick and Murray, 1995
ADR2032 a CDC16-6A::TRP1 CDC23-A-HA CDC27-5A:KAN
R bar1D Rudner and Murray, 2000
KY520   ura3-1 leu2-3,112 trp1-1 GAL  cdc55::LEU2 This work
KY547 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 rho-0 This work
KY596 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 mih1::LEU2 This work
KY600 a ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 swe1::LEU2 This work
KY620   ura3-1 leu2-3,112 trp1-1 ade2-1 his3-11,15 swe1::LEU2 mih1::LEU2 This work
KY630 W303 CLB2-3xHA::URA3 This work
KY631 KY620 CLB2-3xHA::URA3 This work
KY679 a ura3-1 leu2-3 tpd3::LEU2 This work
aColumbia University, New York, NY.
bS. Luneberg Institute, Toronto, Ontario, Canada.
cMassachusetts Institute of Technology, Cambridge, MA.
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phosphate, NaVO3,  -glycerolphosphate, EGTA, and the protease inhibi-
tors PMSF, TPCK, TLCK, leupeptin, pepstatin, and chymostatin at 20–50
 g/ml), and broken by vortexing in the presence of glass beads. Extract
containing 0.15 mg protein was incubated 1 h on ice with 1  g of  -HA
antibody, followed by incubation 1 h with protein A–sepharose beads
(Amersham Pharmacia Biotech). The beads were washed three times in ki-
nase assay buffer (25 mM MOPS, pH 7.2, 15 mM MgCl2, 5 mM EGTA, 1
mM dithiothreitol, 60 mM  -glycerolphosphate, 0.1 mM NaVO3). Reac-
tions were performed at 30 C for 30 min in 10  M kinase assay buffer con-
taining 0.5 mM cold ATP, 2  Ci  [
32P]ATP, and 5  g histone HI. The reac-
tion products were separated by polyacrylamide electrophoresis and
histone HI phosphorylation was quantitated with a phosphorimager.
Protein degradation assay
Ase1 and Pds1 degradation were measured in bar1  cells arrested in G1
with  -factor. Overnight cultures grown in raffinose were diluted in raffi-
nose medium with 1  M  -factor. When more than 90% of the cells had
reached G1 arrest, typically within 3–4 h, E4orf4 expression was induced
by the addition of 3% galactose for 7 h. Pulse–chase analysis was then per-
formed as described (Meimoun et al., 2000). Maintenance of G1 arrest was
confirmed by subjecting an aliquot of the culture taken at the time of the
chase to FACS
® analysis.
Immunoblot analysis and coimmunoprecipitations
For immunoblots, yeast cells were collected at various times after induc-
tion and lysed in the presence of 1.85 M NaOH and 7.4%  -mercaptoeth-
anol. Proteins were TCA precipitated and resuspended in protein loading
buffer (125 mM Tris-HCl, pH 6.8, 1% SDS, 10% glycerol). For visualiza-
tion of E4orf4, proteins were chromatographed on 15% SDS polyacryla-
mide gels and subjected to Western blotting and detection by specific anti-
bodies as previously described (Shtrichman et al., 1999).
For coimmunoprecipitations, yeast extracts were prepared by bead
beating cells for 4 min at 4°C in lysis buffer (250 mM NaCl, 50 mM Tris-
HCl, pH 7.4, 5 mM EDTA, 0.5% Nonidet P-40, 0.1% Triton X-100, 50 mM
NaF, 100  M sodium vanadate, 100 nM okadaic acid [Calbiochem], com-
plete protease inhibitor cocktail [Roche Molecular Biochemicals]). The ly-
sates were spun to separate beads and debris from the clear lysate. The
beads were washed twice more in the lysis buffer, and immunoprecipita-
tions were carried out in the same lysis buffer. Antibodies to E4orf4 were
covalently coupled to protein sepharose beads (Shtrichman et al., 1999).
Antibodies to the HA tag were from Babco, and were used at 1:600. Ly-
sates, antibodies, and protein A beads were rotated for 3 h at 4°C, and then
washed three times in lysis buffer.
Antibodies used in this work were anti-HA (Babco), anti-E4orf4 (Shtrich-
man and Kleinberger, 1998), anti-Tpd3 (from J.R. Broach, Princeton Uni-
versity, Princeton, NJ), and anti-Myc monoclonal (9E10).
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